does semaglutide help with autoimmune and Diseases (Ozempic and Wegovy) Unveiling the Therapeutic Potential of

The trial includes a 48-week primary treatment period, blinded to bimagrumab study drug, followed by a 24-week open-label treatment extension period, and a subsequent 32-week follow-up period after treatment withdrawal

Groups where caution flags are highest People with uncontrolled high blood pressure or known cardiovascular disease

Key points: In the only head-to-head trial, Wegovy produced 15.8% weight loss compared with 6.4% for Saxenda over the same 68-week period Wegovy 7.2 mg (approved January 2026) produces even greater results at 20.7% average weight loss Real-world data from Second Nature shows 19.1% weight loss with semaglutide when combined with behavioural support Semaglutide participants were nearly three times more likely to achieve at least 10% weight loss than liraglutide participants Side effects and tolerability Both medications share a similar side-effect profile, predominantly affecting the gastrointestinal tract

1855 years of age at the time of signing informed consent

n , Representative image of Fura-2AM loaded cells in an ARC brain slice

Should I stop semaglutide because of burping